Detalhe da pesquisa
1.
REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19.
N Engl J Med
; 385(23): e81, 2021 12 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34587383
2.
Association between allergic conditions and COVID-19 susceptibility and outcomes.
Ann Allergy Asthma Immunol
; 132(5): 637-645.e7, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38242353
3.
Attenuating the atopic march: Meta-analysis of the dupilumab atopic dermatitis database for incident allergic events.
J Allergy Clin Immunol
; 151(3): 756-766, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36084766
4.
Casirivimab and Imdevimab for the Treatment of Hospitalized Patients With COVID-19.
J Infect Dis
; 227(1): 23-34, 2022 12 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35895508
5.
Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial.
JAMA
; 327(5): 432-441, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35029629
6.
Suptavumab for the Prevention of Medically Attended Respiratory Syncytial Virus Infection in Preterm Infants.
Clin Infect Dis
; 73(11): e4400-e4408, 2021 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32897368
7.
Efficacy and safety of fasinumab in patients with chronic low back pain: a phase II/III randomised clinical trial.
Ann Rheum Dis
; 80(4): 509-517, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33199274
8.
Thematic analysis to explore patients' experiences with long COVID-19: a conceptual model of symptoms and impacts on daily lives.
BMJ Open
; 14(1): e076992, 2024 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38233059
9.
A phase II placebo-controlled study of tralokinumab in moderate-to-severe asthma.
Eur Respir J
; 41(2): 330-8, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22743678
10.
Serum cholesterol and the risk of developing hormonally driven cancers: A narrative review.
Cancer Med
; 12(6): 6722-6767, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36444895
11.
Effect of proprotein convertase subtilisin/kexin type 9 inhibition on cancer events: A pooled, post hoc, competing risk analysis of alirocumab clinical trials.
Cancer Med
; 12(16): 16859-16868, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37458138
12.
Casirivimab + imdevimab accelerates symptom resolution linked to improved COVID-19 outcomes across susceptible antibody and risk profiles.
Sci Rep
; 13(1): 12784, 2023 08 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37550377
13.
Casirivimab and Imdevimab Treatment Reduces Viral Load and Improves Clinical Outcomes in Seropositive Hospitalized COVID-19 Patients with Nonneutralizing or Borderline Neutralizing Antibodies.
mBio
; 13(6): e0169922, 2022 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36255239
14.
Virologic Efficacy of Casirivimab and Imdevimab COVID-19 Antibody Combination in Outpatients With SARS-CoV-2 Infection: A Phase 2 Dose-Ranging Randomized Clinical Trial.
JAMA Netw Open
; 5(8): e2225411, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35969402
15.
Repeat subcutaneous administration of casirivimab and imdevimab in adults is well-tolerated and prevents the occurrence of COVID-19.
Int J Infect Dis
; 122: 585-592, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35788416
16.
Discriminating sputum-eosinophilic asthma: Accuracy of cutoffs in blood eosinophil measurements versus a composite index, ELEN.
J Allergy Clin Immunol
; 136(3): 812-814.e2, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25913197
17.
Effect of pretreatment with omalizumab on the tolerability of specific immunotherapy in allergic asthma.
J Allergy Clin Immunol
; 125(2): 383-9, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20159249
18.
Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti-IL-5 receptor alpha antibody, in a phase I study of subjects with mild asthma.
J Allergy Clin Immunol
; 125(6): 1237-1244.e2, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20513521
19.
A Retrospective Study of COVID-19-Related Urgent Medical Visits and Hospitalizations After Outpatient COVID-19 Diagnosis in the US.
Adv Ther
; 38(6): 3185-3202, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33961213
20.
Successful Clearance of 300 Day SARS-CoV-2 Infection in a Subject with B-Cell Depletion Associated Prolonged (B-DEAP) COVID by REGEN-COV Anti-Spike Monoclonal Antibody Cocktail.
Viruses
; 13(7)2021 06 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34201591